Jefferies Lifts Est./PT on Abbott Labs (ABT) after In-Line Q1
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/19/2024
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- Hasbro (HAS) Announces Resignation of Cynthia Williams, President of Wizards of the Coast and Hasbro Gaming
- Frontier Communications (FYBR) says third party had gained unauthorized access to portions of its information technology environment
- Ibotta (IBTA) Prices 6.56M Share IPO at $88/sh
- Netflix (NFLX) Tops Q1 EPS by 77c, Offers Guidance
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
- After-hours movers: United Airlines, J.B. Hunt, and more
Abbott (ABT) Guides Q2 EPS of 43c - 45c; Est. at 44c
April 17, 2013 8:15 AM EDTAbbott Laboratories (NYSE: ABT) sees Q2 EPS of $0.43 - $0.45, with the consensus at $0.44.... More
UPDATE: Abbott Laboratories (ABT) Tops Q1 EPS by 1c; Reaffirms FY13 Outlook
April 17, 2013 7:45 AM EDT(Updated - April 17, 2013 8:23 AM EDT)
Abbott Laboratories (NYSE: ABT) reported Q1 EPS of $0.42, $0.01 better than the analyst estimate of $0.41. Revenue for the quarter came in at $5.38 billion versus the consensus estimate of $5.42 billion.
Sales and EPS compare with $5.28 billion and $0.40 reported in the same period last year.
Nutrition saw the largest jump in sales, with operational results popping 9 percent. Medical Device sales... More
